Upgrade to SI Premium - Free Trial

Virios Therapeutics (VIRI) Tops Q3 EPS by 18c

November 14, 2022 7:23 AM

Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.28), $0.18 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

Categories

Earnings

Next Articles